Lyfechannel wins healthfinder.gov mobile app challenge

Laura Pedulli | | Health Exec | Precision Medicine

Lyfechannel’s myfamily app is the winner of the healthfinder.gov Mobile App Challenge, Department of Health and Human Services (HHS) Assistant Secretary Howard K. Koh, MD, MPH, announced on April 30. Lyfechannel, a small, privately held Calif.-based company, beat out 25 other submissions.

The myfamily app enables individuals to manage their family’s health through customized prevention information for each family member, and allows the creation of personal health alerts, and access to information on past medical check-ups and vaccinations. The app focuses on preventive care benefits and services covered by the Affordable Care Act, according to the HHS announcement.

“This app helps put the power of prevention at the fingertips of Americans,” said Koh in the press statement.

About 160 individuals participated as end users to test out and provide feedback to developers on the usefulness and ease of their apps. Apps were judged based on their usability, design, functionality and accuracy, healthfinder.gov branding and sensitivity to health literacy principles, according to HHS.

Access to the myfamily app is here.

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Radiology Business
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

One product is being pulled from the market, and the other is receiving updated instructions for use.

AI in Healthcare
What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?